2013

• Vongsuvanh, R., George, J., Qiao, L., Poorten, D. (2013), Visceral Adiposity In Gastrointestinal And Hepatic Carcinogenesis. Cancer Letters. 330(1), 1-10. [Abstract]

2012

• Booth, D., Ahlenstiel, G., George, J. (2012), Pharmacogenomics of hepatitis C infections: personalizing therapy. Genome Medicine. 4(12), 99. [Abstract]
• Robotin, M., Patton, Y., Kansil, M., Penman, A., George, J. (2012), Cost of treating chronic hepatitis B: Comparison of current treatment guidelines. World Journal of Gastroenterology. 18(42), 6106-6113. [Abstract]
• Patin, E., Kutalik, Z., Guergnon, J., Bibert, S., Nalpas, B., Jouanguy, E., Munteanu, M., Bousquet, L., Argiro, L., Halfon, P., Boland, A., Müllhaupt, B., Semela, D., Dufour, J., Heim, M., Moradpour, D., Cerny, A., Malinverni, R., Hirsch, H., Martinetti, G., Suppiah, V., Stewart, G., Booth, D., George, J., Casanova, J., Bréchot, C., Rice, C., Talal, A., Jacobson, I., Bourlière, M., Theodorou, I., Poynard, T., Negro, F., Pol, S., Bochud, P., Abel, L. (2012), Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. Gastroenterology. 143(5), 1244-52.e1-12. [Abstract]
• Walker, S., George, J., Hebbard, L. (2012), Animal Models of Hepatocellular Carcinoma. In: Molecular Aspects of Hepatocellular Carcinoma. (pp.116-128).United States: Bentham Science Publishers Ltd..
• Qiao, L., George, J., Li, Y., Yan, X. (2012), Molecular Aspects of Hepatocellular Carcinoma. United States: Bentham Science Publishers Ltd..
• Pianko, S., Zeuzem, S., Chuang, W., Foster, G., Sarin, S., Flisiak, R., Lee, C., Andreone, P., Piratvisuth, T., Shah, S., Sood, A., George, J., Gould, M., Komolmit, P., Thongsawat, S., Tanwandee, T., Rasenack, J., Li, Y., Pang, M., Yin, Y., Feutren, G., Jacobson, I. (2012), Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3. Journal of Viral Hepatitis. 19(9), 623-634. [Abstract]
• Rahman, W., Huang, P., Belov, L., Chrisp, J., Christopherson, R., Stapelberg, P., Warner, F., George, J., Bowen, D., Strasser, S., Koorey, D., Sharland, A., McCaughan, G., Shackel, N. (2012), Analysis of human liver disease using a cluster of differentiation (CD) antibody microarray. Liver International. 32(10), 1527-1534. [Abstract]
• Mahady, S., George, J. (2012), Management of nonalcoholic steatohepatitis: an evidence-based approach. Clinics in Liver Disease. 16(3), 631-645. [Abstract]
• Parker, H., Johnson, N., George, J. (2012), Reply to: "The optimal dose of omega-3 supplementation for non-alcoholic fatty liver disease". Journal of Hepatology. , 469-470. [Abstract]
• Vongsuvanh, R., George, J., McLeod, D., van der Poorten, D. (2012), Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 57(2), 392-398. [Abstract]
• Nguyen, V., George, J., van der Poorten, D. (2012), A maxillary mass in a HBV-cirrhotic patient. Liver International. 32(6), 988. [Abstract]
• Keating, S., Hackett, D., George, J., Johnson, N. (2012), Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of Hepatology. 57(1), 157-166. [Abstract]
• Mahady, S., Wong, G., Craig, J., George, J. (2012), Pioglitazone and vitamin E for non alcoholic steatohepatitis: A cost utility analysis. Hepatology. 56(6), 2172-2179. [Abstract]
• Gidding, H., Law, M., Amin, J., Ostapowicz, G., Weltman, M., Macdonald, G., Sasadeusz, J., Haber, P., George, J., Dore, G. (2012), Hepatitis C treatment outcomes in Australian clinics. Medical Journal of Australia. 196(10), 633-637. [Abstract]
• Poutschi, H., George, J. (2012), Reply. Hepatology. , 2039-2040. [Abstract]
• Fischer, J., Böhm, S., Scholz, M., Müller, T., Witt, H., George, J., Sarrazin, C., Susser, S., Schott, E., Suppiah, V., Booth, D., Stewart, G., van Bömmel, F., Brodzinski, A., Fülöp, B., Migaud, P., Berg, T. (2012), Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection. Hepatology. 55(6), 1700-1710. [Abstract]
• Grebely, J., Hellard, M., Applegate, T., Petoumenos, K., Yeung, B., Feld, J., Rawlinson, W., Lloyd, A., George, J., Kaldor, J., Dore, G., Matthews, G. (2012), Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection. AIDS. 26(13), 1653-1661. [Abstract]
• Johnson, N., van Overbeek, D., Chapman, P., Thompson, M., Sachinwalla, T., George, J. (2012), Effect of prolonged exercise and pre-exercise dietary manipulation on hepatic triglycerides in trained men. European Journal of Applied Physiology. 112(5), 1817-1825. [Abstract]
• Thein, H., Walter, S., Gidding, H., Amin, J., Law, M., George, J., Dore, G. (2012), Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort. Hepatology Research. 42(12), 1175-1186. [Abstract]
• Parker, H., Johnson, N., Burdon, C., Cohn, J., O'Connor, H., George, J. (2012), Omega-3 Supplementation and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Journal of Hepatology. 56(4), 944-951. [Abstract]
• Johnson, N., Keating, S., George, J. (2012), Exercise and the liver: implications for therapy in fatty liver disorders. Seminars in Liver Disease. 32(1), 65-79. [Abstract]
• Ahlenstiel, G., Booth, D., George, J. (2012), Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?. Antiviral Therapy. 17(6 Pt B), 1163-1170. [Abstract]
• Pattullo, V., George, J. (2012), The Problem of Insulin Resistance and its Effect on Therapy. In: Advanced Therapy for Hepatitis C. (pp.169-176).United Kingdom: Blackwell Publishing Ltd.

2011

• Poustchi, H., Farrell, G., Strasser, S., Lee, A., McCaughan, G., George, J. (2011), Feasibility of conducting a randomised control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed?. Hepatology. 54(6), 1998-2004. [Abstract]
• Walter, S., Thein, H., Gidding, H., Amin, J., Law, M., George, J., Dore, G. (2011), Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or hepatitis C. Journal of Gastroenterology and Hepatology. 26(12), 1757-1764. [Abstract]
• Mahady, S., Webster, A., Walker, S., Sanyal, A., George, J. (2011), The role of thiazolidinediones in non-alcoholic steatohepatitis- a systematic review and meta analysis. Journal of Hepatology. 55(6), 1383-1390. [Abstract]
• Bhala, N., Angulo, P., van der Poorten, D., Lee, E., Hui, J., Saracco, G., Adams, L., Charatcharoenwitthaya, P., Topping, J., Bugianesi, E., Day, C., George, J. (2011), The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study. Hepatology. 54(4), 1208-1216. [Abstract]
• Adams, L., George, J., Bugianesi, E., Rossi, E., De Boer, W., van der Poorten, D., Ching, H., Bulsara, M., Jeffrey, G. (2011), Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 26(10), 1536-1543. [Abstract]
• Park, G., Wiseman, E., George, J., Katelaris, P., Seow, F., Fung, C., Ngu, M. (2011), Non-invasive Estimation of Liver Fibrosis in Non-alcoholic Fatty Liver Disease Using the (13) C-Caffeine Breath Test. Journal of Gastroenterology and Hepatology. 26(9), 1411-1416. [Abstract]
• Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Irving, W., Powell, E., Hellard, M., Riordan, S., Matthews, G., Sheridan, D., Nattermann, J., Smedile, A., Müller, T., Hammond, E., Dunn, D., Negro, F., Bochud, P., Mallal, S., Ahlenstiel, G., Stewart, G., George, J., Booth, D. (2011), IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study. PLoS Medicine. 8(9), e1001092. [Abstract]
• Raftopoulos, S., George, J., Bourliere, M., Rossi, E., de Boer, W., Jeffrey, G., Bulsara, M., Speers, D., Macquillan, G., Ching, H., Kontorinis, N., Cheng, W., Flexman, J., Fermoyle, S., Rigby, P., Walsh, L., McLeod, D., Adams, L. (2011), Comparison of noninvasive models of fibrosis in chronic hepatitis B. Hepatology International. 6(2), 457-467. [Abstract]
• Thein, H., Walter, S., Gidding, H., Amin, J., Law, M., George, J., Dore, G. (2011), Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007. Journal of Viral Hepatitis. 18(7), e232-e241. [Abstract]
• Jacobson, I., McHutchison, J., Dusheiko, G., Di Bisceglie, A., Reddy, K., Bzowej, N., Marcellin, P., Muir, A., Ferenci, P., Flisiak, R., George, J., Rizzetto, M., Shouval, D., Sola, R., Terg, R., Yoshida, E., Adda, N., Bengtsson, L., Sankoh, A., Kieffer, T., George, S., Kauffman, R., Zeuzem, S. (2011), Telaprevir for previously untreated chronic hepatitis C virus infection. New England Journal of Medicine. 364(25), 2405-2416. [Abstract]
• Liu, Y., Brymora, J., Zhang, H., Smith, B., Ramezani-Moghadam, M., George, J., Wang, J. (2011), Leptin and Acetaldehyde Synergistically Promotes αSMA Expression in Hepatic Stellate Cells by an Interleukin 6-Dependent Mechanism. Alcoholism, Clinical and Experimental Research. 35(5), 921-928. [Abstract]
• Walter, S., Thein, H., Amin, J., Gidding, H., Ward, K., Law, M., George, J., Dore, G. (2011), Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006. Journal of Hepatology. 54(5), 879-886. [Abstract]
• Gidding, H., Law, M., Amin, J., Macdonald, G., Sasadeusz, J., Jones, T., Strasser, S., George, J., Dore, G. (2011), Predictors of deferral of treatment for hepatitis C infection in Australian clinics. Medical Journal of Australia. 194(8), 398-402. [Abstract]
• Pattullo, V., Douglas, M., George, J. (2011), Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?. Expert Review of Gastroenterology & Hepatology. 5(2), 265-277. [Abstract]
• Patterson, S., George, J., Strasser, S., Lee, A., Sievert, W., Nicoll, A., Desmond, P., Roberts, S., Locarnini, S., Bowden, S., Angus, P. (2011), Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut. 60(2), 247-254. [Abstract]
• Poustchi, H., George, J., Esmaili, S., Esna-Ashari, F., Ardalan, G., Sepanlou, S., Alavian, S. (2011), Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. PLoS One. 6(6), e21178. [Abstract]
• Smith, K., Suppiah, V., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Matthews, G., Irving, W., Powell, E., Riordan, S., Ahlenstiel, G., Stewart, G., Bahlo, M., George, J., Booth, D. (2011), Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine. 3(8), 57. [Abstract]
• Hebbard, L., George, J. (2011), Animal models of nonalcoholic fatty liver disease. Nature Reviews. Gastroenterology & Hepatology. 8(1), 35-44. [Abstract]
• Ahlenstiel, G., Booth, D., George, J. (2011), Clinical significance of IL28B gene variation in hepatitis C virus infection. Hot Topics in Viral Hepatitis. .(20), 17-24.

2010

• Grebely, J., Petoumenos, K., Hellard, M., Matthews, G., Suppiah, V., Applegate, T., Yeung, B., Marks, P., Rawlinson, W., Lloyd, A., Booth, D., Kaldor, J., George, J., Dore, G. (2010), Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology. 52(4), 1216-1224. [Abstract]
• Ahlenstiel, G., Booth, D., George, J. (2010), IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice. Journal of gastroenterology. 45(9), 903-10. [Abstract]
• Johnson, N., George, J. (2010), Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.). 52(1), 370-81. [Abstract]
• Milner, K., van der Poorten, D., Trenell, M., Jenkins, A., Xu, A., Smythe, G., Dore, G., Zekry, A., Weltman, M., Fragomeli, V., George, J., Chisholm, D. (2010), Chronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance. Gastroenterology. 138(3), 932-41.e1-3. [Abstract]
• Hebbard, L., George, J. (2010), The chicken or the egg: adipocytes and hepatic insulin resistance. Hepatology. 51(3), 1076-1079. [Abstract]
• Bhala, N., Usherwood, T., George, J. (2010), Nichtalkoholische Fettlebererkrankung [Non-alcoholic fatty liver]. Praxis. 99(3), 187-189. [Abstract]
• Johnson, N., George, J. (2010), An Active Part in Treating Liver Disease. Exercise In Medical Conditions: Exercise And Non-Alcoholic Fatty Liver Disease. SportEx Health. 25, 18-20.
• Mahady, S., George, J. (2010), How to Treat: Hepatitis C infection. Australian Doctor. Feb 2010, 1-6.
• Pattullo, V., George, J. (2010), Managing the Patient with Chronic Viral Hepatitis Receiving Chemotherapy. In: When Cancer Crosses Disciplines: A Physician's Handbook. (pp.813-832).London, UK: Imperial College Press.
• van der Poorten, D., Shahidi, M., Tay, E., Sesha, J., Tran, K., McLeod, D., Milliken, J., Ho, V., Hebbard, L., Douglas, M., George, J. (2010), Hepatitis C virus induces the cannabinoid receptor 1. PloS One. 5(9), pii: e1284. [Abstract]
• Robotin, M., Kansil, M., George, J., Howard, K., Tipper, S., Levy, M., Phung, N., Penman, A. (2010), Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation. BMC Health Services Research. 10, 215. [Abstract]

2009

• Johnson, N., Sachinwalla, T., Walton, D., Smith, K., Armstrong, A., Thompson, M., George, J. (2009), Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology (Baltimore, Md.). 50(0), 1105-12. [Abstract]
• Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M., Bassendine, M., Spengler, U., Dore, G., Powell, E., Riordan, S., Sheridan, D., Smedile, A., Fragomeli, V., Müller, T., Bahlo, M., Stewart, G., Booth, D., George, J. (2009), IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nature Genetics. 41(10), 1100-1104. [Abstract]
• Douglas, M., George, J. (2009), Molecular mechanisms of insulin resistance in chronic hepatitis C. World Journal of Gastroenterology. 15(35), 4356-4364. [Abstract]
• van Hazel, G., Pavlakis, N., Goldstein, D., Olver, I., Tapner, M., Price, D., Bower, G., Briggs, G., Rossleigh, M., Taylor, D., George, J. (2009), Treatment of Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(25), 4089-95. [Abstract]
• Milner, K., Chisholm, D., George, J. (2009), The many faces of hepatitis C: liver disease and type 2 diabetes. Hepatology. 50, 668-670. [Abstract]
• Phung, N., Pera, N., Farrell, G., Leclercq, I., Hou, J., George, J. (2009), Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis. International journal of molecular medicine. 24(2), 171-180. [Abstract]
• Wang, J., Leclercq, I., Brymora, J., Xu, N., Ramezani-Moghadam, M., London, R., Brigstock, D., George, J. (2009), Kupffer Cells Mediate Leptin-Induced Liver Fibrosis. Gastroenterology. 137(2), 713-23. [Abstract]
• St George, A., Bauman, A., Johnston, A., Farrell, G., Chey, T., George, J. (2009), Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology. 50(1), 68-76. [Abstract]
• Milner, K., van der Poorten, D., Xu, A., Bugianesi, E., Kench, J., Lam, K., Chisholm, D., George, J. (2009), Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology. 49(6), 1926-1934. [Abstract]
• Smith, B., George, J. (2009), Adipocyte-hepatocyte crosstalk and the pathogenesis of nonalcoholic fatty liver disease. Hepatology. 49(5), 1765-1767. [Abstract]
• Robotin, M., Kansil, M., Howard, K., George, J., Tipper, S., Dore, G., Levy, M., Penman, A. (2009), Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. Journal of Hepatology. 50(5), 990-998. [Abstract]
• St George, A., Bauman, A., Johnston, A., Farrell, G., Chey, T., George, J. (2009), Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. Journal of gastroenterology and hepatology. 24(0), 399-407. [Abstract]
• George, J., Robotin, M. (2009), Overview: Hepatocellular Carcinoma. Cancer Forum. 33, 80-87.
• van der Poorten, D., Milner, K., George, J. (2009), Effect of adipokines on liver disease in females. In: Female Hepatology: Impact of female sex against progression of liver disease. (pp.191-212).United States: Research Signpost.
• Booth, M., Dobbins, T., Aitken, R., Denney-Wilson, E., Hardy, L., Okely, A., George, J., Sullivan, D., Cowell, C. (2009), Costs of managing conditions associated with obesity among Australian teenagers. Journal of paediatrics and child health. 45(0), 448-56. [Abstract]
• Bhala, N., Usherwood, T., George, J. (2009), Non-alcoholic fatty liver disease. BMJ (Clinical research ed.). 339, b2474. [Abstract]

2008

• Booth, M., George, J., Denney-Wilson, E., Okely, A., Hardy, L., Aitken, R., Dobbins, T. (2008), The population prevalence of adverse concentrations and associations with adiposity of liver tests among Australian adolescents. Journal of paediatrics and child health. 44(12), 686-91. [Abstract]
• van der Poorten, D., George, J. (2008), Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis. Clinics in Liver Disease. 12(4), 805-824. [Abstract]
• Poorten, D., George, J. (2008), Nonalcoholic steatohepatitis is frequently acompanied by metabolic diseases: Reply to the Editor. Hepatology. 48(5), 1729. [Abstract]
• George, J., Denney-Wilson, E., Okely, A., Hardy, L., Aitken, R. (2008), The population distributions, upper normal limits and correlations between liver tests among Australian adolescents. Journal of Paediatrics and Child Health. 44(10), 579-585. [Abstract]
• Cua, I., Hui, J., Kench, J., George, J. (2008), Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md.). 48(3), 723-31. [Abstract]
• van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M., Kench, J., London, R., Peduto, T., Chisholm, D., George, J. (2008), Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. Hepatology (Baltimore, Md.). 48(2), 449-57. [Abstract]
• Johnson, N., Sachinwalla, T., George, J. (2008), In Vitro Proton Magnetic Resonance Spectroscopy of Liver Tissue Informs In Vivo Hepatic Proton Magnetic Resonance Spectroscopy Studies. Reply to the Editor. Hepatology. 48(3), 1016-1017. [Abstract]
• Yan, K., Guirgis, M., Dinh, T., George, J., Dev, A., Lee, A., Zekry, A. (2008), Treatment responses in Asians and Caucasians with chronic hepatitis C infection. World Journal of Gastroenterology. 14(21), 3416-3420. [Abstract]
• van der Poorten, D., Kenny, D., George, J. (2008), Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders. The Medical Journal of Australia. 188(10), 610-614. [Abstract]
• Johnson, N., Walton, D., Sachinwalla, T., Thompson, C., Smith, K., Ruell, P., Stannard, S., George, J. (2008), Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatology. 47(5), 1513-1523. [Abstract]
• Robotin, M., George, J., Supramaniam, R., Sitas, F., Penman, A. (2008), Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy?. The Medical Journal of Australia. 188(6), 363-365. [Abstract]
• George, J. (2008), Evaluating abnormal liver tests. In: Gastroenterology and Hepatology: A Clinical Handbook. (pp.316-326).Australia: Elsevier Australia.
• Wang, J., Brymora, J., George, J. (2008), Roles of adipokines in liver injury and fibrosis. Expert Review of Gastroenterology and Hepatology. 2(1), 47-57.
• Poustchi, H., Mohamadkhani, A., Bowden, S., Montazeri, G., Ayres, A., Revill, P., Farrell, G., Locarnini, S., George, J., Malekzadeh, R. (2008), Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. Journal of Viral Hepatitis. 15(10), 753-760. [Abstract]
• George, J., Liddle, C. (2008), Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets. Molecular Pharmaceutics. 5(1), 49-59. [Abstract]
• Poustchi, H., Negro, F., Hui, J., Cua, I., Brandt, L., Kench, J., George, J. (2008), Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3. Journal of hepatology. 48(1), 28-34. [Abstract]
• Cua, I., George, J. (2008), Insulin resistance, adipocytokines and HCV infection: A missing link?. Hepatology. , 760-761.

2007

• Razali, K., Thein, H., Bell, J., Cooper-Stanbury, M., Dolan, K., Dore, G., George, J., Kaldor, J., Karvelas, M., Li, J., Maher, L., McGregor, S., Hellard, M., Poeder, F., Quaine, J., Stewart, K., Tyrrell, H., Weltman, M., Westcott, O., Wodak, A., Law, M. (2007), Modelling the hepatitis C virus epidemic in Australia. Drug and alcohol dependence. 91(2-3), 228-35. [Abstract]
• Van der Poorten, D., Kenny, D., Butler, T., George, J. (2007), Liver disease in adolescents: A cohort study of high-risk individuals. Hepatology (Baltimore, Md.). 46(6), 1750-8. [Abstract]
• Cua, I., George, J. (2007), Reply:. Hepatology (Baltimore, Md.). 46(6), 2051. [Abstract]
• van der Poorten, D., George, J. (2007), Current and novel therapies for the treatment of nonalcoholic steatohepatitis. Hepatology international. 1(3), 343-354. [Abstract]
• Cua, I., Hui, J., Bandara, P., Kench, J., Farrell, G., McCaughan, G., George, J. (2007), Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines. Hepatology (Baltimore, Md.). 46(1), 66-73. [Abstract]
• Angulo, P., Hui, J., Marchesini, G., Bugianesi, E., George, J., Farrell, G., Enders, F., Saksena, S., Burt, A., Bida, J., Lindor, K., Sanderson, S., Lenzi, M., Adams, L., Kench, J., Therneau, T., Day, C. (2007), The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 45(4), 846-854. [Abstract]
• London, R., George, J. (2007), Pathogenesis of NASH: Animal Models. Clinics in liver disease. 11(1), 55-74. [Abstract]
• Angulo, P., George, J., Marchesini, G., Bugianesi, E., Farrell, G., Day, C. (2007), Author's reply: Non-invasive markers of advanced histology in nonalcoholic fatty liver disease. Gastroenterology. 133(4), 1377-1378.
• Teoh, N., George, J. (2007), Abnormal Liver Function Tests. In: Gastroenterology and Hepatology: A Clinical Handbook. (pp.0).Australia: Churchill Livingstone.